CG肿瘤制药 CGON
$75.99 +$11.19 (+17.27%)
休市 · Nov 7, 10:50 pm ET · 最新盘后价 $76.05 +0.08%
开盘$66.49
昨收$64.80
当日区间$66.17 – $80.03
成交量3.66M
市值$6.74B
市盈率（TTM）–
股息率–
分析师观点
一致评级买入
分析师人数10
平均目标价$92.56+21.8% 较现价
- 买入 100%
最低 $79.00现价 $75.99均值 $92.56最高 $108.00
最新评级变动
已记录的最近20次评级动作给出的目标价区间为$79.00至$108.00，平均为$91.61。
| 日期 | 机构 | 评级 | 目标价 |
|---|---|---|---|
| 10 Sep 2026 | Truist Financial | BUY | – |
| 21 Aug 2026 | UBS | BUY | $90.00 |
| 20 Aug 2026 | UBS | BUY | $90.00 |
| 17 Aug 2026 | Morgan Stanley | BUY | $93.00 |
| 11 Aug 2026 | Truist Financial | BUY | $85.00 |
| 7 Aug 2026 | LifeSci Capital | BUY | $108.00 |
| 7 Aug 2026 | Piper Sandler | BUY | $85.00 |
| 7 Aug 2026 | BofA Securities | BUY | $88.00 |
| 7 Aug 2026 | Truist Financial | BUY | $85.00 |
| 7 Aug 2026 | H.C. Wainwright | BUY | $100.00 |
| 6 Aug 2026 | Cantor Fitzgerald | BUY | $105.00 |
| 6 Aug 2026 | JonesTrading | BUY | $85.00 |
| 6 Aug 2026 | H.C. Wainwright | BUY | $100.00 |
| 6 Aug 2026 | RBC Capital | BUY | $79.00 |
| 29 Jul 2026 | H.C. Wainwright | BUY | $100.00 |
| 28 Jul 2026 | LifeSci Capital | BUY | $108.00 |
| 9 Jul 2026 | Truist Financial | BUY | – |
| 30 Jun 2026 | RBC Capital | BUY | $81.00 |
| 23 Jun 2026 | Piper Sandler | BUY | $82.00 |
| 16 Jun 2026 | JonesTrading | BUY | $85.00 |
暂无评论——快来第一个聊聊 CGON。
登录后参与讨论。